Cardinal Health (CAH) CEO receives 187,965 performance share units settling 2026

Rhea-AI Filing Summary

Cardinal Health Inc. Chief Executive Officer Jason M. Hollar reported an equity award. On August 4, 2026, he received 187,965 common shares at no cost, reported as a grant, award, or other acquisition. A footnote states the award reflects performance share units that will settle on August 15, 2026. Following this award, his directly held common shares position was 387,965.

Insider Trade Summary

Net Buyer: 187,965 shares

Net Buy 1 txn

Insider Hollar Jason M.

Role Chief Executive Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Shares F1	187,965	$0.00	$0.00

Holdings After Transaction: Common Shares — 387,965 shares (Direct)

Footnotes (1)

1. F1. Reflects performance share units that will settle on August 15, 2026.

Key Figures

Equity award size: 187,965 common shares Shares held after transaction: 387,965 common shares Grant price per share: $0.0000 per share +1 more

4 metrics

Equity award size 187,965 common shares Grant, award, or other acquisition reported on August 4, 2026

Shares held after transaction 387,965 common shares Directly held Cardinal Health common shares following the reported award

Grant price per share $0.0000 per share Stated price for the 187,965 awarded common shares

Settlement date of performance share units August 15, 2026 Footnote states performance share units will settle on this date

Key Terms

performance share units, grant, award, or other acquisition

2 terms

performance share units financial

"Reflects performance share units that will settle on August 15, 2026."

Performance share units are a type of company stock award given to employees that depend on the company meeting specific goals or targets. If these goals are achieved, the employee receives shares or the value of shares; if not, they may receive little or no compensation. This aligns employees’ interests with the company's success and encourages performance that benefits investors.

grant, award, or other acquisition financial

"Transaction code description is grant, award, or other acquisition."

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/06/2026 - 06:06 AM Accepted by SEC EDGAR 08/06/2026 - 06:02 AM Learn about SEC filing dates

FAQ

What equity award did Cardinal Health (CAH) CEO Jason M. Hollar report?

Jason M. Hollar received 187,965 common shares of Cardinal Health on August 4, 2026, reported as a grant, award, or other acquisition. A footnote explains this represents performance share units that will settle on August 15, 2026, increasing his directly held holdings to 387,965 shares.

How many Cardinal Health (CAH) shares does the CEO hold after this Form 4 transaction?

After the reported award, Jason M. Hollar directly holds 387,965 common shares of Cardinal Health. This figure reflects his position following the acquisition of 187,965 shares linked to performance share units scheduled to settle on August 15, 2026.

At what price were the Cardinal Health (CAH) shares granted to CEO Jason M. Hollar?

The 187,965 Cardinal Health common shares granted to Jason M. Hollar carried a stated price of $0.0000 per share. This indicates they were awarded at no cash cost to him as part of an equity compensation arrangement, tied to performance share units.

Are Jason M. Hollar’s reported Cardinal Health (CAH) holdings direct or indirect?

The filing reports Jason M. Hollar’s holdings as direct ownership, coded as D. After the transaction, he directly owns 387,965 common shares of Cardinal Health, reflecting the inclusion of shares associated with performance share units scheduled to settle in 2026.

When will the performance share units reported by Cardinal Health (CAH) CEO settle?

The footnote states that the reported award reflects performance share units that will settle on August 15, 2026. Settlement on that date will determine how these units translate into Cardinal Health common shares under the terms of the award.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hollar Jason M.

(Last) (First) (Middle)

7000 CARDINAL PLACE

(Street)

DUBLIN OHIO 43017

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CARDINAL HEALTH INC [ CAH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/04/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	08/04/2026		A(1)		187,965	A	$0	387,965	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects performance share units that will settle on August 15, 2026.

Remarks:

	/s/ Laura C. Dhaliwal, Attorney-in-fact	08/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)